Clinical Trials in Michigan

Showing 12361-12380 of 13,890 trials

Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)

NCT00732940

The purpose of this study is to test the safety and tolerability of repeated subcutaneous (SC) doses of belimumab in subjects with SLE.

Systemic Lupus Erythematosus

Human Genome Sciences Inc.56 participantsStarted Oct 2008

Birmingham, Alabama, United States • Long Beach, California, United States • Tampa, Florida, United States +8 more locations

COMPLETEDPhase 441 miles

Open-label Trial of Acthar Gel in Subjects With Moderate to Severe Active Systemic Lupus Erythematosus

NCT01769937

Systemic lupus erythematosus is a serious and potentially life-threatening condition with significant unmet medical need. The aim of this Investigator Initiated, single center, open-label study is to evaluate the efficacy and safety of a daily subcutaneously (SQ) injection of H.P. Acthar Gel for 10 days with an optional 5 day rescue period for non-responders after day 10 dose. The primary objective of this study is to evaluate whether the addition of H.P. Acthar Gel to standard treatment of lupus will ameliorate the intensity of flares as measured by changes in SLEDAI score, Patient and Physician global assessments.

Lupus Erythematosus Systemic Exacerbation

Fiechtner, Justus J., M.D., P.C.10 participantsStarted Oct 2012

Lansing, Michigan, United States

Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)

Open-label Trial of Acthar Gel in Subjects With Moderate to Severe Active Systemic Lupus Erythematosus

Find Trials by Condition in Michigan

Trial Of IW001 in Patients With Idiopathic Pulmonary Fibrosis

Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder

Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT)

A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN)

A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale

Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus

Balloon REmodeling Antrostomy THErapy Study

3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

Open Label Extension Study of STX209 (Arbaclofen) in Autism Spectrum Disorders

An Open Label Extension Study in Subjects With Fragile X Syndrome

A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment

A Study of Combination Therapy With PEGASYS (Pegylated Interferon Alfa-2a (40KD)) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 2 or 3 Who Do Not Achieve a Rapid Viral Response

A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss

Case-Control Viramune (Nevirapine) Toxicogenomics Study

Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic Cancer

Prevention Trial of Family Focused Treatment in Youth at Risk for Psychosis